Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model.
about
Harnessing the antitumor potential of macrophages for cancer immunotherapyRole of tumor associated macrophages in tumor angiogenesis and lymphangiogenesisA role for G-CSF and GM-CSF in nonmyeloid cancersMolecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseasesLoss of HIF-1α in macrophages attenuates AhR/ARNT-mediated tumorigenesis in a PAH-driven tumor modelStructure and cancer immunotherapy of the B7 family member B7xHIF transcription factors, inflammation, and immunity.The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.Redox control of inflammation in macrophages.Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.Prolyl 4-hydroxylases, master regulators of the hypoxia response.Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.Intestinal hypoxia and hypoxia-induced signalling as therapeutic targets for IBD.Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study.Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials.Hypoxic Signalling in Tumour Stroma.
P2860
Q26828883-3063B4D6-8C44-4083-B784-B2A2228E729BQ26865533-4D975E76-667F-4AF1-9986-9889C80985FEQ27002515-1C029ACB-0E94-446F-A25B-9BCE69C3E5B6Q28297656-E0A48C45-377A-4A04-AE3A-A1B056308395Q28828484-A274F6C9-5D26-41B5-8C46-EE91FD06C679Q34605921-70ADD5F7-C0D6-4A5E-AC57-C4E659CBF714Q35137138-6811A8B2-0AA0-4131-B18F-2038FB85072CQ35212733-B0E0B556-C2D1-4A96-94A5-185C34444996Q35989342-760D4464-D874-4583-B7D4-E8EB08D9D92CQ37032282-9BC0ABA2-9575-4596-B6FA-9C3ADF327101Q37202015-3147DC98-A990-495E-AA36-BD197F2317E0Q37606594-61845681-A35B-4DCF-8593-88603F71AA4BQ38089239-97E90CF3-02E0-4755-92DF-9326F0136517Q38246724-BE5F9821-3FCE-4709-8132-7161DB0FBA98Q45570735-E94E5231-82E8-46F4-AAFD-5A8D1C5498E0Q46260887-89C9EC2B-0FC7-43CB-BA01-139C0DFD7C85Q46721561-6E25C351-CF5A-4BA9-8794-19A34567EE07Q50052760-5D84A780-3AD8-47A1-8730-4883A1031A5FQ55284922-4AB2B003-F3AD-45F6-8F45-65C847DBD4D8
P2860
Stabilization of HIF-2α induces sVEGFR-1 production from tumor-associated macrophages and decreases tumor growth in a murine melanoma model.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@ast
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@en
type
label
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@ast
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@en
prefLabel
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@ast
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@en
P2093
P2860
P356
P1476
Stabilization of HIF-2α induce ...... th in a murine melanoma model.
@en
P2093
Clay B Marsh
Gary S Phillips
Laura A Sumner
Timothy D Eubank
Yijie Wang
P2860
P304
P356
10.4049/JIMMUNOL.1103817
P407
P50
P577
2012-08-06T00:00:00Z